Innate Pharma SA (IPHA)
2.305
-0.72
(-23.68%)
USD |
NASDAQ |
Dec 16, 16:00
2.39
+0.08
(+3.69%)
After-Hours: 20:00
Innate Pharma Shareholders Equity (Quarterly): 30.87M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| DBV Technologies SA | 54.03M |
| Cellectis SA | 129.42M |
| Genfit SA | 75.11M |
| Inventiva SA | -84.74M |
| Nanobiotix SA | -23.34M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 162.39M |
| Total Liabilities (Quarterly) | 131.52M |
| Debt to Equity Ratio | 1.233 |
| Current Ratio | 2.920 |
| Net Debt Paydown Yield | 1.26% |